SCHEMBL26237686

SCHEMBL26237686

CN(C)/C=N\c1ncnn2c([C@@H]3O[C@]4(C)C(O)[C@@]45OC(C)(C)O[C@@H]35)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26831296 1.00 — —
SCHEMBL26238566 0.85 — —
SCHEMBL26239588 0.81 — —
SCHEMBL25776452 0.81 POLRMT (0.38) —
SCHEMBL26237533 0.76 — —
SCHEMBL26236065 0.74 — —
SCHEMBL25393033 0.73 KDM4E (0.31) —
SCHEMBL26831371 0.72 — —
SCHEMBL26237130 0.72 MAOB (0.31) —
SCHEMBL26823251 0.71 KDM4E (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382940-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2023-11-30 — — US disclosed
WO-2023168254-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2023-09-07 — — WO disclosed
Send feedback